Tobias Ahy, based in Stockholm, SE, is currently a Commercial and Clinical Analyst at Infant Bacterial Therapeutics AB, bringing experience from previous roles at STUNS Life science, AbbVie and Elsa Science. Tobias Ahy holds a 2020 - 2022 Master's degree in Bioentrepreneurship @ Karolinska Institutet. Tobias Ahy has 1 email on RocketReach.